Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15397 total
Pharvaris heads into the week after Q1 earnings with a complex mix: a clean beat, a fresh equity raise, meaningful insider selling, and short sellers retreating sharply. The clearest catalyst was Q1 results delivered…
Hims & Hers Health heads into the post-earnings week in an awkward position: a stock that had rallied nearly 29% over the prior month gave back a large chunk of those gains in a single session, yet short sellers —…
INBS heads into mid-May with a sharp divergence between price momentum and short-side positioning — the stock is up 31% on the week, but short sellers have simultaneously doubled down. The most striking data point is…
RVPH enters its most consequential week of the year not because of earnings — though those came too — but because the stock is being delisted from Nasdaq, with shares moving to the OTCQB market on May 14. The delisting…
DoorDash heads into the week after its Q1 report with short sellers adding positions at pace, analysts sharpening pencils on price targets, and a new competitive threat emerging from Amazon's delivery expansion. Short…
QuantumScape has spent the week posting one of its sharpest rallies in months, up 16% in five days to $8.42, with news that the solid-state battery maker is targeting AI and defense licensing opportunities adding fuel…
OLMA heads into a defining two-week stretch carrying its heaviest short interest in months, a freshly beaten Q1 print, and a key oncology conference on the horizon — all while the stock trades down 13% over the past…
EZGO Technologies has undergone one of the most violent positioning collapses seen in a micro-cap this year — short interest has risen more than 5,000% in a single week as the stock falls 98% month-to-date. The short…
IRD heads into its May 20 earnings with short interest at its highest level in months and an unusual cluster of insider sells already logged — a charged setup for a $370M gene therapy micro-cap. Short interest has…
Eos Energy Enterprises is navigating one of the sharpest short squeezes in the clean-energy storage space — yet with 30% of the float still borrowed, the tension between the bulls who just received a major catalyst and…
Nyxoah just delivered its strongest revenue quarter yet — then watched the stock slip anyway. Q1 2026 results came in ahead of expectations on every key line. Revenue hit €6.37 million, up roughly sixfold year-on-year…
HYLN just dropped a Q1 earnings beat and rallied 16% on the week — yet short sellers have barely flinched, leaving the stock in an unusual tug of war between improving fundamentals and a stubbornly elevated short…
IBEX Limited enters the post-earnings stretch with three signals pointing in the same direction — and a $20 million share repurchase program announced today that sharpens the setup further. The catalyst is last week's…
C4 Therapeutics heads into the week of May 11 with a striking divergence: short sellers are heavily dug in at more than a quarter of the free float, yet options traders are leaning bullish at a pace not seen in…
JZXN — Jiuzi Holdings — is a $1.6 million market-cap Chinese EV retail stock that just became one of the most expensive names to borrow in the market. The dominant story this week is a violent repricing in the lending…
DoubleDown Interactive closed its latest earnings week with a sharp analyst target cut and a stock price that has still run 34% in a month — the tension between those two facts defines the current setup. The most…
PMV Pharmaceuticals heads into its May 15 investor call with a conflicting set of signals: a Q1 earnings beat, a short-interest spike, and fresh analyst caution. The most notable piece of recent Street activity came…
COMPASS Pathways reported Q1 earnings on May 13 that beat estimates and flagged an accelerated FDA review timeline, delivering a jolt to a stock that had already climbed 69% over the prior month — and leaving a…
Praxis Precision Medicine heads into mid-May with a sharpening divergence between a cautious short base and a bullish analyst consensus that just got a fresh upward nudge. Short interest is meaningfully elevated but…
Shift4 Payments enters the week in an intriguing position: short interest is still among the heaviest in the payments universe, borrowing costs have collapsed, and the options market just registered its most defensive…
